Invesco
TERN

Invesco’s Terns Pharmaceuticals TERN Stock Holding History

Invesco’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-304,487
Closed -$16.1M – 3935
2026
Q1 		$16.1M Sell
304,487
-301,760
-50% -$12.4M ﹤0.01% 1574
2025
Q4 		$24.5M Buy
606,247
+128,573
+27% +$2.97M ﹤0.01% 1357
2025
Q3 		$3.59M Buy
477,674
+383,140
+405% +$2.45M ﹤0.01% 2379
2025
Q2 		$353K Buy
94,534
+36,189
+62% +$113K ﹤0.01% 3309
2025
Q1 		$161K Buy
58,345
+34,945
+149% +$143K ﹤0.01% 3557
2024
Q4 		$130K Buy
23,400
+2,753
+13% +$18.6K ﹤0.01% 3593
2024
Q3 		$172K Sell
20,647
-654
-3% -$5.38K ﹤0.01% 3546
2024
Q2 		$145K Sell
21,301
-862
-4% -$5.22K ﹤0.01% 3701
2024
Q1 		$145K Buy
22,163
+372
+2% +$2.43K ﹤0.01% 3700
2023
Q4 		$141K Sell
21,791
-19,159
-47% -$101K ﹤0.01% 3631
2023
Q3 		$206K Buy
40,950
+18,955
+86% +$120K ﹤0.01% 3584
2023
Q2 		$192K Sell
21,995
-552,182
-96% -$6.44M ﹤0.01% 3621
2023
Q1 		$6.8M Buy
+574,177
New +$5.49M ﹤0.01% 2071

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Invesco's TERN Position: Q2 2026 in Review

Invesco sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 304,487 shares — an estimated $16.1M sold.

Invesco first reported a position in TERN in Q1 2023 and held it in 13 quarters. The position peaked at $24.5M in Q4 2025. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Invesco reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Invesco sold 304,487 Terns Pharmaceuticals shares in Q2 2026, an estimated $16.1M.
  • Invesco first reported a position in Terns Pharmaceuticals in Q1 2023 and held it in 13 quarters.
  • Invesco's Terns Pharmaceuticals position peaked at $24.5M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.